The RAVI Registry: A Prospective, Multi-Center, Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
Status: Completed
Location: See all (6) locations...
Intervention Type: Device
Study Type: Observational
SUMMARY
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Subject is ≥ 18 years old
• Subject is scheduled for a procedure for treatment with HydroPearl microspheres using radial access.
• Subject is willing and able to complete follow-up requirements
• Subject is willing and able to sign a written Informed Consent form prior to participating in the registry.
Locations
United States
California
University of California - Los Angeles
Los Angeles
Illinois
Rush University Medical Center
Chicago
Missouri
SLU Department of Radiology
Saint Louis
North Carolina
UNC
Chapel Hill
New York
Mount Sinai
New York
South Carolina
Medical University of South Carolina
Charleston
Time Frame
Start Date: 2020-02-06
Completion Date: 2023-03-11
Participants
Target number of participants: 99
Treatments
Treatment with HydroPearl via radial access
all patients will be in the same group/cohort in this open-label, single-arm, observational registry.
Authors
Related Therapeutic Areas
Sponsors
Leads: Terumo Medical Corporation